Teva Pharmaceutical is not overpriced in terms of valuation.

The company is charting new heights beyond CopaxoneRelated Stocks: TEVA, PFE, BMY, ABBV, RDY, MRK, IBB, XBI, SPY…

Read More: https://www.gurufocus.com/news/2444937/teva-pharmaceutical-valuation-not-expensive